Stem Cell Reconstructive Market Overview By Sources, Cell Types Application and End Users Forecast Till 2030. The Stem cell reconstructive market is expected to reach USD 4,673.3 Million by 2030 at 20.6% CAGR during the forecast period 2022-2030. Stem cell reconstructive is a procedure involving the usages of a patient’s own adipose tissue to increase the fat volume in the area of reconstruction and thus promoting 3Dimentional reconstruction in patients who have undergone a trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or who need the reconstructive surgery as a result of an accident or injury. Stem cell reconstructive surgeries are also used in cosmetic or plastic surgeries.
Over the past few years, increasing reconstructive surgeries led by the increasing number of accidents, limbs amputation and implants are fostering the growth in the stem cell reconstructive market. Besides, the factors such as increasing geriatric populations, rising number of patients suffering from chronic diseases, and continuous development in the technology are escalating the market on the global level.
On the other hand, factors such as high cost of stem cell reconstructive surgeries and stringent regulatory approvals are acting as a headwind obstructing the market growth. Besides, high risks of adverse effects associated with these surgeries can also impede the market growth. Nevertheless, factors such as the increasing need for alternative treatments, government support for the development of new products, and rising healthcare expenditure are expected to support the market growth over the assessment period.
Key Players:
The global stem cell reconstructive market is led by some of the fervent players including Cytori Therapeutics Inc. (U.S), Baxter (US), Eleveflow (France), NuVasive Inc. (US), Mesoblast Ltd. (Australia), Osiris Therapeutics, Inc. (US), TAKARA BIO INC.(Japan), Micronit Microfluidics (Netherlands), Tigenix (Belgium), Celyad (Belgium), Cynata (Australia), Capricor Therapeutics (Canada), Pfizer Inc. (US), Astellas Pharma US, Inc. (US), StemCells Inc (US), Caladrius (US), and STEMCELL Technologies Inc. (US).
Stem Cell Reconstructive Market - Segments
MRFR has segmented its analysis into five key dynamics for the convenience of understanding;
By Sources : Allogeneic, Autologous (bone marrow, adipose tissue, and blood.), and Syngeneic among other.
By Cell Types : Embryonic Stem Cell and Adult Stem Cell among others.
By Applications : Cancer, Diabetes, Traumatic Skin Defect, and Severe Burn among others.
By End-Users : Hospital and Research Institutes among others.
By Regions : Europe, North America, APAC and the Rest-of-the-World (RoW).
Stem Cell Reconstructive Market - Regional Analysis
Globally North America market dominates the stem cell reconstructive market Research report with the largest share. Factors such as the notable increase in incidences of stem cell reconstructive surgeries and encouraging research and development in healthcare drive the market growth in the region. Additional factors such as the increasing uptake of advanced technologies and high healthcare expenditures are substantiating the market growth.
Owing to the rising demands for stem cell reconstructive procedures, this market is expected to create a larger revenue pocket globally, by 2023. The US among other North American countries, backed by the high expenditure on healthcare coupled with the increasing demand for stem cell reconstructive treatments, accounts for the major contributor to the market growth.
The European accounts for the second largest market for stem cell reconstructive, globally, attributing to the recent advancements in the medical technology and the augmenting these techniques in the region. Additionally, the presence of a substantial patient population alongside the rising healthcare expenditure facilitates the growth of the regional market. Besides, public & private sectors' support and funding for research & development are expected to fuel the market growth in the region over the review period.
The Asia Pacific region is rapidly emerging as a lucrative market for stem cell reconstructive due to the increasing incidents of these surgeries and the development of related technologies mainly in the countries such as India, China, and Japan. The APAC market backed by the rising demand for these procedures and increasing adoption of the technologies is projected to register a phenomenal CAGR during the forecast period.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
